Organisation paid for research Program year 2025 Source: CMS Open Payments

VCU Health

Neither a doctor nor a teaching hospital

Research payments

$312,953

14 payments

Through program year 2025, VCU Health is reported as receiving $312,953 in research payments, across 14 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $31,077 5
2024 Research $81,523 4
2023 Research $109,254 3
2022 Research $67,409 1
2019 Research $23,690 1

Breakdown

Who paid Research payments · program years 2019–2025
  1. Galvanize Therapeutics, Inc $286,901 12 payments
  2. Vertex Pharmaceuticals Incorporated $23,690 1 payment
  3. Amgen Inc. $2,362 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. CS006 RheOx Pivotal $286,901 12 payments
  2. Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury $23,690 1 payment
  3. Prevention of breast cancer by Denosumab in females carrying a BRCA1 or 2 mutation $2,362 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record